Andrew Lo

BBIO

Andrew Lo serves as Director at BridgeBio Pharma, Inc. (BBIO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$1.32M

Total Sells

2 trades

$10.17M

Net Position

Net Seller

$8.85M

Companies Traded

BBIO, ABCL

Active Period

Dec 2021 – Nov 2025

4 total trades

Most Recent

Sell BBIO

Nov 17, 2025 · $6.32M

Andrew Lo's Insider Trading at BridgeBio Pharma, Inc. (BBIO)

Buys

1 · $98.8K

Sells

2 · $10.17M

Total Shares Bought

7,500

Total Shares Sold

195,599

BBIO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Nov 17, 2025↗	Sell	95,599	$66.11	$6.32M
May 2, 2025↗	Sell	100,000	$38.50	$3.85M
Dec 29, 2021↗	Buy	7,500	$13.18	$98.8K

Andrew Lo's Insider Trading at AbCellera Biologics Inc. (ABCL)

Buys

1 · $1.22M

Sells

0 · $0.00

Total Shares Bought

86,938

Total Shares Sold

ABCL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 3, 2021↗	Buy	86,938	$14.02	$1.22M	0

Related Insiders

Hannah Valantine

director

BBIOSell · Mar 10, 2026

Andrea Ellis

director

BBIOSell · Mar 4, 2026

Maricel Apuli

officer: Chief Accounting Officer

BBIOSell · Feb 26, 2026

Neil Kumar

Chief Executive Officer

BBIOSell · Feb 19, 2026

Neil Kumar

director, officer: Chief Executive Officer

BBIOSell · Feb 19, 2026

Randal W. Scott

director

BBIOSell · Feb 17, 2026

Maricel Apuli

Chief Accounting Officer

BBIOSell · Feb 17, 2026

Thomas Trimarchi

President and CFO

BBIOSell · Feb 17, 2026

Explore More Insider Trading Data

BBIO Insider Trading Activity

View all insider trades at BridgeBio Pharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity